Gryphon Investors, a leading middle-market private equity firm, signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics (collectively "Revision Goodier").
WHO: For more than two decades, Revision Skincare has provided dermatologists, plastic surgeons, and medical spas with clinically proven, high-performing skincare products. The portfolio includes well-known franchises such as Nectifirm, Intellishade, D·E·J, and Revox, sold in more than 10 countries.
Since 1922, Irving, TX-based Goodier Cosmetics has been a trusted developer and manufacturer in cosmetic and OTC topical skincare solutions. Differentiated by an industry-renowned Innovation Center of Excellence, Goodier, along with its team of R&D chemists, engineers, and regulatory experts, remains at the forefront of market trends, new technologies, ingredients, and advancements in formulation science.
Based in San Francisco, Gryphon Investors is a leading private equity firm focused on profitably growing and competitively enhancing middle-market companies in partnership with experienced management. The firm has managed over $7.5 billion of equity investments and capital since 1997. Gryphon targets making equity investments of $50 million to $300 million in portfolio companies with enterprise values ranging from approximately $100 million to $600 million.
IN THEIR OWN WORDS: Gryphon Operating Partner Mike Ferry said, "Revision has a unique position as a high-growth independent company in a compelling market. Skincare consumers are becoming more discerning about the products they use, and we are excited to invest in Revision's mission to help bring carefully formulated and highly efficacious skincare products to a global customer base."
Eddie Douglas, Principal in Gryphon's Consumer Group, noted, "We are thrilled to partner with Maria [Maria Carell, Revision Goodier CEO] and her outstanding team to support Revision's movement to bring scientific credibility, quality, innovation, and elegance to the professional skincare market. We are equally excited about the opportunity to build on Goodier's differentiated capabilities and deliver world-class service to some of the fastest growing brands across the prestige beauty and personal care space."
Ms. Carell commented, "We are delighted to partner with the team at Gryphon as we enter our next phase of growth. Gryphon is an ideal partner given their knowledge of skincare, consumer health, and professionally-endorsed brands, and their investment will allow us to accelerate the incredible momentum we have built over the last few years."
Matt Farron, Partner and Head of Gryphon's Consumer Group, added, "Revision Goodier represents a bullseye opportunity for Gryphon and leverages our proactive focus of investing behind leading efficacious skincare brands. We are proud to be partnering with the Revision Goodier management team, leaders in the clinical, efficacious skincare category, and to be supporting the team through their next phase of growth."
2 Article(s) Remaining